Published in Arch Biochem Biophys on October 15, 1981
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
Identification of heregulin, a specific activator of p185erbB2. Science (1992) 4.17
Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology (2001) 3.13
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84
The erbB3 gene product is a receptor for heregulin. J Biol Chem (1994) 2.63
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res (2000) 2.24
Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett (1999) 2.06
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A (1997) 1.89
Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci U S A (1995) 1.73
Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci (1996) 1.45
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene (1999) 1.39
The influence of heregulins on human Schwann cell proliferation. J Neurosci (1995) 1.34
Regulation of the acetylcholine receptor epsilon subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation. Neuron (1995) 1.32
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res (1996) 1.25
Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem (1994) 1.19
Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4. FEBS Lett (1998) 1.17
CD20: a gene in search of a function. Semin Oncol (2000) 1.14
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey. Histopathology (2001) 1.13
Assessing genetic heterogeneity in production cell lines: detection by peptide mapping of a low level Tyr to Gln sequence variant in a recombinant antibody. Biotechnology (N Y) (1993) 1.12
Incorporation and distribution of selenium into thiolase from Clostridium kluyveri. J Biol Chem (1985) 1.10
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. Cancer Res (2001) 1.10
Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms. Oncogene (2009) 1.09
Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis. J Biol Chem (1998) 1.03
Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene (1997) 1.00
Kinetics of papain-catalyzed hydrolysis of -N-benzoyl-L-arginine-p-nitroanilide. Biochemistry (1973) 1.00
Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology (1998) 0.98
Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. Am J Respir Cell Mol Biol (2000) 0.95
Simultaneous single-step purification of thiolase and NADP-dependent 3-hydroxybutyryl-CoA dehydrogenase from Clostridium kluyveri. Anal Biochem (1984) 0.94
Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells. J Biol Chem (1997) 0.94
Heregulins and the ErbB-2/3/4 receptors in gliomas. J Neurooncol (1997) 0.92
The biology of human epidermal growth factor receptor 2. Curr Oncol Rep (1999) 0.92
Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. J Biol Chem (1996) 0.92
Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene (1996) 0.92
Purification and immunological studies of selenoprotein A of the clostridial glycine reductase complex. J Biol Chem (1987) 0.91
Sulfhydryl oxidase-catalyzed conversion of xanthine dehydrogenase to xanthine oxidase. Arch Biochem Biophys (1981) 0.91
High-resolution solution structure of the EGF-like domain of heregulin-alpha. Biochemistry (1996) 0.90
Molecular weight, subunit structure, and amino acid composition of the branched chain amino acid aminotransferase of Salmonella typhimurium. Biochemistry (1974) 0.90
Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins. J Clin Microbiol (1990) 0.89
A potential role for activated HER-2 in prostate cancer. Semin Oncol (2000) 0.88
Isolation and characterization of acetylornithine delta-transaminase of wild-type Escherichia coli W. Comparison with arginine-inducible acetylornithine delta-transaminase. Arch Biochem Biophys (1979) 0.86
Dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium salts. Water-soluble environmentally sensitive protein reagents. J Biol Chem (1970) 0.86
A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2. J Biol Chem (1999) 0.85
Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase. Biotechnology (N Y) (1995) 0.84
Development of herceptin. Breast Dis (2000) 0.84
Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display. J Biol Chem (1998) 0.84
Preparation and characterization of thionyl chloride-activated succinamidopropyl-glass as a covalent immobilization matrix. J Appl Biochem (1984) 0.84
Biochemical characterization of recombinant human nerve growth factor. J Neurochem (1992) 0.84
Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. Biotechnol Bioeng (2000) 0.83
Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assay. Anal Biochem (1996) 0.82
Isolation and properties of a soluble sialidase from the culture fluid of Chinese hamster ovary cells. Glycobiology (1993) 0.82
Catalytic effect of sulfhydryl oxidase on the formation of three-dimensional structure in chymotrypsinogen A. Arch Biochem Biophys (1978) 0.82
Protein sorting by high-performance liquid chromatography. I. Biomimetic interaction chromatography of recombinant human deoxyribonuclease I on polyionic stationary phases. J Chromatogr (1993) 0.82
Sulphydryl oxidase: oxidation of sulphydryl groups and the formation of three-dimensional structure in proteins. Ciba Found Symp (1979) 0.81
Resolution of renal sulfhydryl oxidase from gamma-glutamyltransferase by covalent chromatography on cysteinylsuccinamidopropyl-glass. Biochem Biophys Res Commun (1982) 0.81
Rat liver and small intestine produce proapolipoprotein A-I which is slowly processed to apolipoprotein A-I in the circulation. J Biol Chem (1984) 0.80
2-Chloromethyl-4-nitrophenyl (N-carbobenzoxy)glycinate. A new reagent designed to introduce an environmentally sensitive conformational probe near the active site of papain. Biochemistry (1973) 0.80
Structure of papain modified by reaction with 2-chloromethyl-4-nitrophenyl N-carbobenzoxyglycinate. Biochemistry (1979) 0.79
Vinca alkaloids XXXIII [1]. Microbiological conversions of vincaleukoblastine (VLB, vinblastine), an antitumor alkaloid from Vinca rosea. Linn. Helv Chim Acta (1974) 0.79
Effects of in vivo heregulin beta1 treatment in wild-type and ErbB gene-targeted mice depend on receptor levels and pregnancy. Am J Pathol (2001) 0.79
Resolution of sulphydryl oxidase from gamma-glutamyltransferase in bovine milk by covalent chromatography on cysteinylsuccinamidopropyl-glass. Biochem J (1983) 0.79
Backbone dynamics of the EGF-like domain of heregulin-alpha. J Mol Biol (1998) 0.79
Sulfhydryl oxidase from milk. Methods Enzymol (1987) 0.78
Effect of hydroxynitrobenzylation of tryptophan-177 on reactivity of active site cysteine-25 in papain. Arch Biochem Biophys (1981) 0.78
Purification and characterization of alpha-L-fucosidase from Chinese hamster ovary cell culture supernatant. Glycobiology (1994) 0.77
Structural requirements for ErbB2 transactivation. Semin Oncol (2001) 0.77
Incorporation of 15N from ammonium into the N-linked oligosaccharides of an immunoadhesin glycoprotein expressed in Chinese hamster ovary cells. Glycobiology (1999) 0.77
Kinetic mechanism and specificity of bovine milk sulphydryl oxidase. Biochem J (1984) 0.77
Structural transitions of soluble and immobilized chymotrypsinogen A in urea and guanidinium chloride as measured by fluorescence. Arch Biochem Biophys (1978) 0.77
Establishment of Schwann cell lines from normal adult and embryonic rat dorsal root ganglia. J Neurosci Methods (1996) 0.77
Some kinetic characteristics of immobilized protomers and native dimers of mitochondrial malate dehydrogenase: an examination of the enzyme mechanism. Biochemistry (1985) 0.76
Purification and properties of sulfhydryl oxidase from bovine pancreas. Arch Biochem Biophys (1988) 0.76
Renaturation of soluble and immobilized ribonuclease: are the polypeptide folding pathways for structure formation the same for soluble proteins and for proteins associated with a surface? J Appl Biochem (1985) 0.76
Tissue distribution of mammalian sulfhydryl oxidase. Arch Biochem Biophys (1984) 0.76
Glycylglycyl-L-cysteine as a substrate for renal sulfhydryl oxidase (glutathione oxidase). Biochim Biophys Acta (1985) 0.76
Selenomethionine-containing thiolase and 3-hydroxybutyryl-CoA dehydrogenase from Clostridium kluyveri. Curr Top Cell Regul (1985) 0.75
The reaction of dimethyl (2-hydroxy-5-nitrobenzyl) sulfonium salts with tryptophan ethyl ester. Arch Biochem Biophys (1971) 0.75
Characterization of selenomethionine in proteins. Methods Enzymol (1984) 0.75
Procedure for covalently immobilizing enzymes which permits subsequent release. Biochemistry (1979) 0.75
Reversible allosteric modulation of activity of immobilized hepatic glutamate dehydrogenase. Biochem Biophys Res Commun (1974) 0.75
Nonreversibility in the reductive denaturation of chymotrypsinogen A. 1. Proc Soc Exp Biol Med (1972) 0.75
2-Acetoxy-5-nitrobenzyl chloride. A regent designed to introduce a reporter group near the active site of chymotrypsin. Biochim Biophys Acta (1969) 0.75
Covalently bound glutamate dehydrogenase for studies of subunit association and allosteric regulation. Methods Enzymol (1976) 0.75
The phosphoglucomutase reaction: investigation of enzyme dephosphorylation during its reaction with substrate. Biochim Biophys Acta (1967) 0.75
Immobilization as a means of investigating the acquisition of tertiary structure in chymotrypsinogen. Methods Enzymol (1976) 0.75
Chain refolding and subunit interactions in enzyme molecules covalently bound to a solid matrix. Adv Exp Med Biol (1974) 0.75
Reaction of 2-hydroxy-5-nitrobenzylated carboxypeptidase A with 14 C-1-fluoro-2,4-dinitrobenzene. Biochem Biophys Res Commun (1971) 0.75
Enzymatic enhancement of the catalytic rate of sulfhydryl oxidase. Biochim Biophys Acta (1987) 0.75
A kinetic analysis of the enhanced catalytic efficiency of papain modified by 2-hydroxy-5-nitrobenzylation. Biochemistry (1973) 0.75
Interaction of proflavine with 2-hydroxy-5-nitrobenzylated papain. Biochem Biophys Res Commun (1982) 0.75
Anti-IgG immobilized controlled-pore glass. Thionyl chloride-activated succinamidopropyl-glass as a covalent immobilization matrix. Appl Biochem Biotechnol (1992) 0.75
Kinetics and spectral properties of carboxypeptidase A labeled with the 2-hydroxy-5-nitrobenzyl reporter group. J Biol Chem (1973) 0.75
Labeling of cysteine-containing peptides with 2-nitro-5-thiobenzoic acid. Anal Biochem (1985) 0.75
Enzymatic removal of formalin-fixed tissues from polyester arteries, and its effect on physical properties of fibers. J Biomed Mater Res (1982) 0.75
Assay of enzyme-catalyzed oxygen-dependent disulfide bond formation. Methods Enzymol (1987) 0.75
[39] Modification of proteins with active benzyl halides. Methods Enzymol (1972) 0.75
Air-reoxidation of reduced, denatured chymotrypsinogen A covalently attached to a solid matrix. Biochem Biophys Res Commun (1972) 0.75